MedImmune LLC:企業の戦略的SWOT分析

◆英語タイトル:MedImmune LLC - Strategic SWOT Analysis Review
◆商品コード:DATA904C15788
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MedImmune LLC – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture, and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibodies and other next-generation molecules targeting various diseases. MedImmune undertakes research in the areas of cancer treatment; respiratory; inflammation and autoimmune; and cardiovascular disorders and metabolic diseases. It also develops vaccines for the prevention of infectious diseases. The company operates three R&D centers in Gaithersburg, Maryland; Cambridge, the UK; and Mountain View, California. MedImmune is headquartered in Gaithersburg, Maryland, the US.

MedImmune LLC Key Recent Developments

Feb 14,2019 “MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
Dec 04,2018 CELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery
Sep 14,2018 US FDA Approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia[Newswire : Healthcare-BW]
Aug 20,2018 AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
Jun 18,2018 N4 Pharma: Update on Nuvec

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MedImmune LLC – Key Facts
MedImmune LLC – Key Employees
MedImmune LLC – Key Employee Biographies
MedImmune LLC – Major Products and Services
MedImmune LLC – History
MedImmune LLC – Company Statement
MedImmune LLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
MedImmune LLC – Business Description
MedImmune LLC – SWOT Analysis
SWOT Analysis – Overview
MedImmune LLC – Strengths
MedImmune LLC – Weaknesses
MedImmune LLC – Opportunities
MedImmune LLC – Threats
MedImmune LLC – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
MedImmune LLC, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 14, 2019: “MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
Dec 04, 2018: CELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery
Sep 14, 2018: US FDA Approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia[Newswire : Healthcare-BW]
Aug 20, 2018: AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
Jun 18, 2018: N4 Pharma: Update on Nuvec
Apr 04, 2018: AstraZeneca’s early and late-stage oncology portfolio showcased at AACR annual meeting and ELCC
Feb 28, 2018: MedImmune to create stand-alone company for early-stage inflammation and autoimmunity biologics
Jan 01, 2018: New Bio-Incubator and Life-Science Accelerator Capability Launches at the Babraham Research Campus
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
MedImmune LLC, Key Facts
MedImmune LLC, Key Employees
MedImmune LLC, Key Employee Biographies
MedImmune LLC, Major Products and Services
MedImmune LLC, History
MedImmune LLC, Other Locations
MedImmune LLC, Subsidiaries
MedImmune LLC, Key Competitors
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
MedImmune LLC, Recent Deals Summary

List of Figures
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[MedImmune LLC:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OHB SE:企業の戦略・SWOT・財務分析
    SummaryOHB SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Detai …
  • Cree Inc (CREE)-エネルギー分野:企業M&A・提携分析
    Summary Cree, Inc. (Cree) is a lighting class LED's, LED lighting, and semiconductor solutions provider, that develops and manufactures semiconductor materials and devices principally based on silicon carbide (SiC), gallium nitride (GaN), and other related compounds. Cree’s product portfolio include …
  • Buck Institute for Research on Aging-製薬・医療分野:企業M&A・提携分析
    Summary Buck Institute for Research on Aging (Buck Institute) is a healthcare institute that conducts research and offers educational services. The institute concentrates on understanding the connection between aging and chronic disease. It works to understand how normal aging contributes to the dev …
  • Oncolys BioPharma Inc (4588)-医療機器分野:企業M&A・提携分析
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OB …
  • The Emirates Group:企業の戦略・SWOT・財務分析
    SummaryThe Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Astellas Pharma Europe Ltd.(製薬・医療分野):企業M&A動向
    Summary Astellas Pharma Europe Ltd. (Astellas Europe), a subsidiary of Astellas Pharma Inc. is a pharmaceutical company. The company researches discovers and develops new pharmaceutical products for the healthcare markets. It offers products for treatment in the therapeutic areas such as oncology, t …
  • Shenzhen Salubris Pharmaceuticals Co Ltd (002294):製薬・医療:M&Aディール及び事業提携情報
    Summary Shenzhen Salubris Pharmaceuticals Co Ltd (Salubris) is a pharmaceutical company that research, develops, manufactures and distributes pharmaceutical and healthcare products. The company produces tablet, capsule, and injection formulations and active pharmaceutical ingredients, among others. …
  • Coca-Cola Icecek A.S.:企業の戦略・SWOT・財務情報
    Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kungsleden AB:企業のM&A・提携・投資分析
    Kungsleden AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kungsleden AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Elecon Engineering Company Ltd. (ELECON):企業の財務及び戦略的SWOT分析
    Summary Elecon Engineering Company Ltd. (Elecon) is an industrial equipment manufacturer that offers motors. The company manufactures material handling equipment, industrial geared motors and reducers, mining equipment and casting processes. Its products include helical gear boxes, planetary gear, w …
  • RehabCare Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RehabCare Group, Inc. Mergers a …
  • Sodexo SA:企業の戦略・SWOT・財務情報
    Sodexo SA - Strategy, SWOT and Corporate Finance Report Summary Sodexo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Total Gabon SA (EC)(石油・ガス分野):企業M&A動向
    Summary Total Gabon SA (Total Gabon) is an oil and gas company. The company explores and extracts hydrocarbons. Its activities include domain mining and exploration, production, and marketing of hydrocarbons. The company also operates a terminal to receive, store, and dispose oil. Total Gabon is hea …
  • Royal KPN N.V.:企業のM&A・提携・投資分析
    Royal KPN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal KPN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Angel Acquisition Corp. (Formerly Palomar Enterprises, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Angel Acquisition Corp. (Former …
  • DiaSorin S.p.A (DIA)-医療機器分野:企業M&A・提携分析
    Summary DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techni …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Aspial Corporation Limited (A30):企業概要、財務及び戦略的SWOT分析
    Aspial Corporation Limited (A30) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PT Tigaraksa Satria Tbk (TGKA):企業の財務・戦略的SWOT分析
    PT Tigaraksa Satria Tbk (TGKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ban Leong Technologies Ltd (B26):企業の財務及び戦略的SWOT分析
    Summary Ban Leong Technologies Ltd (Ban Leong) is a technology company that distributes IT products such as computer peripherals, accessories and other multimedia products. The company’s products include audio and video products, communication devices, computer components, memory disks and storage d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆